Amanda R. Leonti

834 citations
32 papers · 193 indexed · h-index 8
Topics
Acute Myeloid Leukemia Research (20 papers)CAR-T cell therapy research (8 papers)Protein Degradation and Inhibitors (7 papers)

In The Last Decade

Amanda R. Leonti

30 papers receiving 191 citations

Peers

Amanda R. Leonti
Comparison fields: 5 of 33
  • Hematology 113
  • Molecular Biology 99
  • Oncology 55
  • Genetics 36
  • Immunology 35
Replace Jean‐Valère Malfuson with:
Jean‐Valère Malfuson France
Yongsheng Ruan China
Torsten Haferlach Germany
Naghmeh Niktoreh Germany
E. S. J. M. de Bont Netherlands
Zinia J. Kwidama Netherlands
Nicole R. Grieselhuber United States
Heather Ogana United States
Mara Molkentin Germany
Federica Cattina Italy
Amanda R. Leonti relative to Jean‐Valère Malfuson France Jean‐Valère Malfuson's profile →
Citations per field
00.5×9.5×
Jean‐Valère Malfuson · 1×
Citations per year

Countries citing papers authored by Amanda R. Leonti

Since Specialization
Citations

This map shows the geographic impact of Amanda R. Leonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda R. Leonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda R. Leonti more than expected).

Fields of papers citing papers by Amanda R. Leonti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda R. Leonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda R. Leonti. The network helps show where Amanda R. Leonti may publish in the future.

Co-authorship network of co-authors of Amanda R. Leonti

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda R. Leonti. A scholar is included among the top collaborators of Amanda R. Leonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda R. Leonti. Amanda R. Leonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3 13
4 7
5 23
6 1
7 17
8 7
9 1
10 3
11 1
12 2
13 55
14 2
15 12
16 3
17 1
18 1
19 1
20 2

About Amanda R. Leonti

Amanda R. Leonti is a scholar working on Hematology, Cancer Research and Immunology, having authored 32 papers that have together received 193 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (20 papers), CAR-T cell therapy research (8 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Hematology (113 citations), Genetics (36 citations) and Oncology (55 citations). Amanda R. Leonti has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Soheil Meshinchi, Rhonda E. Ries, Michael R. Loken, Laura Pardo, Jenny L. Smith, Todd A. Alonzo, Richard Aplenc, E. Anders Kolb, Lisa Eidenschink Brodersen and Alan S. Gamis. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026